BOLTON SECURITIES CORPORATION’s Century Therapeutics IPSC Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.6K	Buy	+10,000	New	+$21K	﹤0.01%	1423

Other funds holding IPSC

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's IPSC Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Century Therapeutics (IPSC) in Q1 2026: 10,000 shares worth $22.6K. The stake represents ﹤0.01% of the portfolio and ranks #1423 among its holdings.

73 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

BOLTON SECURITIES CORPORATION held 10,000 shares of Century Therapeutics worth $22.6K as of Q1 2026.
Century Therapeutics was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
Century Therapeutics made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #1423 holding.
73 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.